News
RSVP for this Virtual Series on Business Ethics & the Pandemic Moderated by Christopher Michaelson, PhD
This three part series is hosted by the University of St. Thomas' Opus College of Business via the
The Melrose & The Toro Company Center for Principled Leadership.
Patients With Vulnerable Immune Systems Worry Vaccine Exemptions May Put Them in Peril
Clinical Ethicist Joel Wu, JD, MPH, MA, HEC-C weighs in on the dilemma.
Immunocompromised patients worry vaccine exemptions put them in peril
Clinical Ethicist, Joel Wu, JD, MPH, MA, HEC-C discusses how hospital staff can respond to questions about their vaccination status.
Doctors fighting racial health disparities face threats, harassment
JP Leider, PhD pushes back on the success of political agendas to remove public health policies addressing health disparities based on race.
New Article: Using qualitative, community-based input to steer post–coronavirus disease 2019 pharmacy practice in substance use
Laura Palombi, PharmD, MPH, PAT, AE-C co-authors a new article.
Minnesota's 2021 death toll well above expected total despite vaccine
Public Health Policy researcher JP Leider, PhD, comments on the link between deaths and vaccination status, particularly among those under 65.
Former Trump adviser falsely claims states are rationing scarce covid treatments based largely on race
JP Leider, PhD discusses the facts.
Are Pfizer's Covid pills going to highest-risk patients? Inside the U.S. rollout
JP Leider, PhD comments on equity guardrails when resources are scarce.
It's Been Quite a Week in Legislation for the Public Health Workforce
JP Leider, PhD, writes in favor of recent Minnesota based bills aimed at tackling recruitment and retention of public health workers.
As with vaccines, equity becomes an issue with COVID-19 medicines
Commentary on inequitable access to life-saving medications by JP Leider, PhD.